Global Opioid Withdrawal Treatment Market

Opioid Withdrawal Treatment Comprehensive Study by Type (Outpatient Treatment, Inpatient Treatment), Drug Type (Nonsteroidal Anti-Inflammatory Drugs, Anti-Nausea Medications, Analgesics, Natural Sleep Supplements, Others), End Use (Hospital & Clinics, Home Care Settings, Other), Sales Channel (Online Stores, Hospital Pharmacy, Retail Pharmacies) Players and Region - Global Market Outlook to 2027

Opioid Withdrawal Treatment Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Opioid Withdrawal Treatment
The global Opioid Withdrawal Treatment market is expected to witness high demand in the forecasted period due to the increasingly large population of people who falls victim to the ills of drug abuse. Opioid withdrawal is a syndrome of distressing psychological and physical symptoms which occur after therapeutic discontinuation and dosage reduction of opioids. The main opioid withdrawal symptoms reflect the increased activity of the autonomic nervous system. Opioids withdrawal symptoms such as insomnia, muscle aches, and pain, abdominal cramping, vomiting, and diarrhea. The growing cases of chronic diseases will help to boost the global demand in the forecasted period.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Merck & Co. (United States), Teva Pharmaceutical Industries Ltd (Israel), Pfizer Inc. (United States), Novartis International AG (Switzerland), Sanofi S.A.(France), Johnson & Johnson (United States), F. Hoffmann-La Roche Ltd (Switzerland), Bayer AG (Germany), VIVITROL (Ireland) and Elsevier (Netherlands) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Opioid Withdrawal Treatment market by Type (Outpatient Treatment and Inpatient Treatment) and Region.



On the basis of geography, the market of Opioid Withdrawal Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Drug Type, the sub-segment i.e. Nonsteroidal Anti-Inflammatory Drugs will boost the Opioid Withdrawal Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Use, the sub-segment i.e. Hospital & Clinics will boost the Opioid Withdrawal Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sales Channel, the sub-segment i.e. Online Stores will boost the Opioid Withdrawal Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
August 26, 2019: Johnson & Johnson and its Janssen Pharmaceutical Companies today announced they will appeal the ISD 572 million civil judgment entered in Cleveland County District Court in the State of Oklahoma’s lawsuit against opioid manufacturers. The Company is confident it has strong grounds to appeal this decision.
February 19, 2019 Sandoz, a Novartis division, announced that the authorized generic of SUBOXONE 1 (buprenorphine and naloxone) Sublingual Film (CIII) by Indivior Inc. in all four dosage strengths is immediately available in the US. February 19, 2019 Sandoz, a Novartis division, today announced that the authorized generic of SUBOXONE 1 (buprenorphine and naloxone) Sublingual Film (CIII) by Indivior Inc. in all four dosage strengths is immediately available in the US.


Market Drivers
  • Increasing Number of Young People Addicted to Opioids
  • Rising Popularity of Rehab Centers

Opportunities
  • Rising Investment on Research and Development
  • Government Initiatives to Prevent Youngsters from Opioids
  • Increasing NGOs Centers Worldwide

Restraints
  • Slow Recovery Process

Challenges
  • Lack of Awareness among Rural Areas


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Opioid Withdrawal Treatment Providers, Venture Capitalists and Private Equity Firms and Government Regulatory and Research Organizations

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Outpatient Treatment
  • Inpatient Treatment
By Drug Type
  • Nonsteroidal Anti-Inflammatory Drugs
  • Anti-Nausea Medications
  • Analgesics
  • Natural Sleep Supplements
  • Others

By End Use
  • Hospital & Clinics
  • Home Care Settings
  • Other

By Sales Channel
  • Online Stores
  • Hospital Pharmacy
  • Retail Pharmacies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Young People Addicted to Opioids
      • 3.2.2. Rising Popularity of Rehab Centers
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness among Rural Areas
    • 3.4. Market Trends
      • 3.4.1. Strict Regulations on Supply of Opioids
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Opioid Withdrawal Treatment, by Type, Drug Type, End Use, Sales Channel and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Opioid Withdrawal Treatment (Value)
      • 5.2.1. Global Opioid Withdrawal Treatment by: Type (Value)
        • 5.2.1.1. Outpatient Treatment
        • 5.2.1.2. Inpatient Treatment
      • 5.2.2. Global Opioid Withdrawal Treatment by: Drug Type (Value)
        • 5.2.2.1. Nonsteroidal Anti-Inflammatory Drugs
        • 5.2.2.2. Anti-Nausea Medications
        • 5.2.2.3. Analgesics
        • 5.2.2.4. Natural Sleep Supplements
        • 5.2.2.5. Others
      • 5.2.3. Global Opioid Withdrawal Treatment by: End Use (Value)
        • 5.2.3.1. Hospital & Clinics
        • 5.2.3.2. Home Care Settings
        • 5.2.3.3. Other
      • 5.2.4. Global Opioid Withdrawal Treatment by: Sales Channel (Value)
        • 5.2.4.1. Online Stores
        • 5.2.4.2. Hospital Pharmacy
        • 5.2.4.3. Retail Pharmacies
      • 5.2.5. Global Opioid Withdrawal Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Opioid Withdrawal Treatment (Price)
      • 5.3.1. Global Opioid Withdrawal Treatment by: Type (Price)
  • 6. Opioid Withdrawal Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck & Co. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Teva Pharmaceutical Industries Ltd (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pfizer Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis International AG (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sanofi S.A.(France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Johnson & Johnson (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. F. Hoffmann-La Roche Ltd (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bayer AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. VIVITROL (Ireland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Elsevier (Netherlands)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Opioid Withdrawal Treatment Sale, by Type, Drug Type, End Use, Sales Channel and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Opioid Withdrawal Treatment (Value)
      • 7.2.1. Global Opioid Withdrawal Treatment by: Type (Value)
        • 7.2.1.1. Outpatient Treatment
        • 7.2.1.2. Inpatient Treatment
      • 7.2.2. Global Opioid Withdrawal Treatment by: Drug Type (Value)
        • 7.2.2.1. Nonsteroidal Anti-Inflammatory Drugs
        • 7.2.2.2. Anti-Nausea Medications
        • 7.2.2.3. Analgesics
        • 7.2.2.4. Natural Sleep Supplements
        • 7.2.2.5. Others
      • 7.2.3. Global Opioid Withdrawal Treatment by: End Use (Value)
        • 7.2.3.1. Hospital & Clinics
        • 7.2.3.2. Home Care Settings
        • 7.2.3.3. Other
      • 7.2.4. Global Opioid Withdrawal Treatment by: Sales Channel (Value)
        • 7.2.4.1. Online Stores
        • 7.2.4.2. Hospital Pharmacy
        • 7.2.4.3. Retail Pharmacies
      • 7.2.5. Global Opioid Withdrawal Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Opioid Withdrawal Treatment (Price)
      • 7.3.1. Global Opioid Withdrawal Treatment by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Opioid Withdrawal Treatment: by Type(USD Million)
  • Table 2. Opioid Withdrawal Treatment Outpatient Treatment , by Region USD Million (2016-2021)
  • Table 3. Opioid Withdrawal Treatment Inpatient Treatment , by Region USD Million (2016-2021)
  • Table 4. Opioid Withdrawal Treatment: by Drug Type(USD Million)
  • Table 5. Opioid Withdrawal Treatment Nonsteroidal Anti-Inflammatory Drugs , by Region USD Million (2016-2021)
  • Table 6. Opioid Withdrawal Treatment Anti-Nausea Medications , by Region USD Million (2016-2021)
  • Table 7. Opioid Withdrawal Treatment Analgesics , by Region USD Million (2016-2021)
  • Table 8. Opioid Withdrawal Treatment Natural Sleep Supplements , by Region USD Million (2016-2021)
  • Table 9. Opioid Withdrawal Treatment Others , by Region USD Million (2016-2021)
  • Table 10. Opioid Withdrawal Treatment: by End Use(USD Million)
  • Table 11. Opioid Withdrawal Treatment Hospital & Clinics , by Region USD Million (2016-2021)
  • Table 12. Opioid Withdrawal Treatment Home Care Settings , by Region USD Million (2016-2021)
  • Table 13. Opioid Withdrawal Treatment Other , by Region USD Million (2016-2021)
  • Table 14. Opioid Withdrawal Treatment: by Sales Channel(USD Million)
  • Table 15. Opioid Withdrawal Treatment Online Stores , by Region USD Million (2016-2021)
  • Table 16. Opioid Withdrawal Treatment Hospital Pharmacy , by Region USD Million (2016-2021)
  • Table 17. Opioid Withdrawal Treatment Retail Pharmacies , by Region USD Million (2016-2021)
  • Table 18. South America Opioid Withdrawal Treatment, by Country USD Million (2016-2021)
  • Table 19. South America Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 20. South America Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 21. South America Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 22. South America Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 23. Brazil Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 24. Brazil Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 25. Brazil Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 26. Brazil Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 27. Argentina Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 28. Argentina Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 29. Argentina Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 30. Argentina Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 31. Rest of South America Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 32. Rest of South America Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 33. Rest of South America Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 34. Rest of South America Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 35. Asia Pacific Opioid Withdrawal Treatment, by Country USD Million (2016-2021)
  • Table 36. Asia Pacific Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 37. Asia Pacific Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 38. Asia Pacific Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 39. Asia Pacific Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 40. China Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 41. China Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 42. China Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 43. China Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 44. Japan Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 45. Japan Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 46. Japan Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 47. Japan Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 48. India Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 49. India Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 50. India Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 51. India Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 52. South Korea Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 53. South Korea Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 54. South Korea Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 55. South Korea Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 56. Taiwan Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 57. Taiwan Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 58. Taiwan Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 59. Taiwan Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 60. Australia Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 61. Australia Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 62. Australia Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 63. Australia Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 66. Rest of Asia-Pacific Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 67. Rest of Asia-Pacific Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 68. Europe Opioid Withdrawal Treatment, by Country USD Million (2016-2021)
  • Table 69. Europe Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 70. Europe Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 71. Europe Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 72. Europe Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 73. Germany Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 74. Germany Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 75. Germany Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 76. Germany Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 77. France Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 78. France Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 79. France Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 80. France Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 81. Italy Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 82. Italy Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 83. Italy Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 84. Italy Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 85. United Kingdom Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 86. United Kingdom Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 87. United Kingdom Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 88. United Kingdom Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 89. Netherlands Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 90. Netherlands Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 91. Netherlands Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 92. Netherlands Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 93. Rest of Europe Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 94. Rest of Europe Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 95. Rest of Europe Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 96. Rest of Europe Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 97. MEA Opioid Withdrawal Treatment, by Country USD Million (2016-2021)
  • Table 98. MEA Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 99. MEA Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 100. MEA Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 101. MEA Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 102. Middle East Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 103. Middle East Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 104. Middle East Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 105. Middle East Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 106. Africa Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 107. Africa Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 108. Africa Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 109. Africa Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 110. North America Opioid Withdrawal Treatment, by Country USD Million (2016-2021)
  • Table 111. North America Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 112. North America Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 113. North America Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 114. North America Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 115. United States Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 116. United States Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 117. United States Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 118. United States Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 119. Canada Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 120. Canada Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 121. Canada Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 122. Canada Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 123. Mexico Opioid Withdrawal Treatment, by Type USD Million (2016-2021)
  • Table 124. Mexico Opioid Withdrawal Treatment, by Drug Type USD Million (2016-2021)
  • Table 125. Mexico Opioid Withdrawal Treatment, by End Use USD Million (2016-2021)
  • Table 126. Mexico Opioid Withdrawal Treatment, by Sales Channel USD Million (2016-2021)
  • Table 127. Opioid Withdrawal Treatment: by Type(USD/Units)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Opioid Withdrawal Treatment: by Type(USD Million)
  • Table 139. Opioid Withdrawal Treatment Outpatient Treatment , by Region USD Million (2022-2027)
  • Table 140. Opioid Withdrawal Treatment Inpatient Treatment , by Region USD Million (2022-2027)
  • Table 141. Opioid Withdrawal Treatment: by Drug Type(USD Million)
  • Table 142. Opioid Withdrawal Treatment Nonsteroidal Anti-Inflammatory Drugs , by Region USD Million (2022-2027)
  • Table 143. Opioid Withdrawal Treatment Anti-Nausea Medications , by Region USD Million (2022-2027)
  • Table 144. Opioid Withdrawal Treatment Analgesics , by Region USD Million (2022-2027)
  • Table 145. Opioid Withdrawal Treatment Natural Sleep Supplements , by Region USD Million (2022-2027)
  • Table 146. Opioid Withdrawal Treatment Others , by Region USD Million (2022-2027)
  • Table 147. Opioid Withdrawal Treatment: by End Use(USD Million)
  • Table 148. Opioid Withdrawal Treatment Hospital & Clinics , by Region USD Million (2022-2027)
  • Table 149. Opioid Withdrawal Treatment Home Care Settings , by Region USD Million (2022-2027)
  • Table 150. Opioid Withdrawal Treatment Other , by Region USD Million (2022-2027)
  • Table 151. Opioid Withdrawal Treatment: by Sales Channel(USD Million)
  • Table 152. Opioid Withdrawal Treatment Online Stores , by Region USD Million (2022-2027)
  • Table 153. Opioid Withdrawal Treatment Hospital Pharmacy , by Region USD Million (2022-2027)
  • Table 154. Opioid Withdrawal Treatment Retail Pharmacies , by Region USD Million (2022-2027)
  • Table 155. South America Opioid Withdrawal Treatment, by Country USD Million (2022-2027)
  • Table 156. South America Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 157. South America Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 158. South America Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 159. South America Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 160. Brazil Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 161. Brazil Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 162. Brazil Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 163. Brazil Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 164. Argentina Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 165. Argentina Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 166. Argentina Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 167. Argentina Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 168. Rest of South America Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 169. Rest of South America Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 170. Rest of South America Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 171. Rest of South America Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 172. Asia Pacific Opioid Withdrawal Treatment, by Country USD Million (2022-2027)
  • Table 173. Asia Pacific Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 174. Asia Pacific Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 175. Asia Pacific Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 176. Asia Pacific Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 177. China Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 178. China Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 179. China Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 180. China Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 181. Japan Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 182. Japan Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 183. Japan Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 184. Japan Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 185. India Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 186. India Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 187. India Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 188. India Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 189. South Korea Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 190. South Korea Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 191. South Korea Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 192. South Korea Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 193. Taiwan Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 194. Taiwan Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 195. Taiwan Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 196. Taiwan Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 197. Australia Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 198. Australia Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 199. Australia Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 200. Australia Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 201. Rest of Asia-Pacific Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 202. Rest of Asia-Pacific Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 203. Rest of Asia-Pacific Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 204. Rest of Asia-Pacific Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 205. Europe Opioid Withdrawal Treatment, by Country USD Million (2022-2027)
  • Table 206. Europe Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 207. Europe Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 208. Europe Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 209. Europe Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 210. Germany Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 211. Germany Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 212. Germany Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 213. Germany Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 214. France Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 215. France Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 216. France Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 217. France Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 218. Italy Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 219. Italy Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 220. Italy Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 221. Italy Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 222. United Kingdom Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 223. United Kingdom Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 224. United Kingdom Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 225. United Kingdom Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 226. Netherlands Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 227. Netherlands Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 228. Netherlands Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 229. Netherlands Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 230. Rest of Europe Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 231. Rest of Europe Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 232. Rest of Europe Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 233. Rest of Europe Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 234. MEA Opioid Withdrawal Treatment, by Country USD Million (2022-2027)
  • Table 235. MEA Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 236. MEA Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 237. MEA Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 238. MEA Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 239. Middle East Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 240. Middle East Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 241. Middle East Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 242. Middle East Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 243. Africa Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 244. Africa Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 245. Africa Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 246. Africa Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 247. North America Opioid Withdrawal Treatment, by Country USD Million (2022-2027)
  • Table 248. North America Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 249. North America Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 250. North America Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 251. North America Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 252. United States Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 253. United States Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 254. United States Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 255. United States Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 256. Canada Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 257. Canada Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 258. Canada Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 259. Canada Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 260. Mexico Opioid Withdrawal Treatment, by Type USD Million (2022-2027)
  • Table 261. Mexico Opioid Withdrawal Treatment, by Drug Type USD Million (2022-2027)
  • Table 262. Mexico Opioid Withdrawal Treatment, by End Use USD Million (2022-2027)
  • Table 263. Mexico Opioid Withdrawal Treatment, by Sales Channel USD Million (2022-2027)
  • Table 264. Opioid Withdrawal Treatment: by Type(USD/Units)
  • Table 265. Research Programs/Design for This Report
  • Table 266. Key Data Information from Secondary Sources
  • Table 267. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Opioid Withdrawal Treatment: by Type USD Million (2016-2021)
  • Figure 5. Global Opioid Withdrawal Treatment: by Drug Type USD Million (2016-2021)
  • Figure 6. Global Opioid Withdrawal Treatment: by End Use USD Million (2016-2021)
  • Figure 7. Global Opioid Withdrawal Treatment: by Sales Channel USD Million (2016-2021)
  • Figure 8. South America Opioid Withdrawal Treatment Share (%), by Country
  • Figure 9. Asia Pacific Opioid Withdrawal Treatment Share (%), by Country
  • Figure 10. Europe Opioid Withdrawal Treatment Share (%), by Country
  • Figure 11. MEA Opioid Withdrawal Treatment Share (%), by Country
  • Figure 12. North America Opioid Withdrawal Treatment Share (%), by Country
  • Figure 13. Global Opioid Withdrawal Treatment: by Type USD/Units (2016-2021)
  • Figure 14. Global Opioid Withdrawal Treatment share by Players 2021 (%)
  • Figure 15. Global Opioid Withdrawal Treatment share by Players (Top 3) 2021(%)
  • Figure 16. Global Opioid Withdrawal Treatment share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Merck & Co. (United States) Revenue: by Geography 2021
  • Figure 20. Teva Pharmaceutical Industries Ltd (Israel) Revenue, Net Income and Gross profit
  • Figure 21. Teva Pharmaceutical Industries Ltd (Israel) Revenue: by Geography 2021
  • Figure 22. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Pfizer Inc. (United States) Revenue: by Geography 2021
  • Figure 24. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 25. Novartis International AG (Switzerland) Revenue: by Geography 2021
  • Figure 26. Sanofi S.A.(France) Revenue, Net Income and Gross profit
  • Figure 27. Sanofi S.A.(France) Revenue: by Geography 2021
  • Figure 28. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 29. Johnson & Johnson (United States) Revenue: by Geography 2021
  • Figure 30. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2021
  • Figure 32. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Bayer AG (Germany) Revenue: by Geography 2021
  • Figure 34. VIVITROL (Ireland) Revenue, Net Income and Gross profit
  • Figure 35. VIVITROL (Ireland) Revenue: by Geography 2021
  • Figure 36. Elsevier (Netherlands) Revenue, Net Income and Gross profit
  • Figure 37. Elsevier (Netherlands) Revenue: by Geography 2021
  • Figure 38. Global Opioid Withdrawal Treatment: by Type USD Million (2022-2027)
  • Figure 39. Global Opioid Withdrawal Treatment: by Drug Type USD Million (2022-2027)
  • Figure 40. Global Opioid Withdrawal Treatment: by End Use USD Million (2022-2027)
  • Figure 41. Global Opioid Withdrawal Treatment: by Sales Channel USD Million (2022-2027)
  • Figure 42. South America Opioid Withdrawal Treatment Share (%), by Country
  • Figure 43. Asia Pacific Opioid Withdrawal Treatment Share (%), by Country
  • Figure 44. Europe Opioid Withdrawal Treatment Share (%), by Country
  • Figure 45. MEA Opioid Withdrawal Treatment Share (%), by Country
  • Figure 46. North America Opioid Withdrawal Treatment Share (%), by Country
  • Figure 47. Global Opioid Withdrawal Treatment: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Merck & Co. (United States)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Pfizer Inc. (United States)
  • Novartis International AG (Switzerland)
  • Sanofi S.A.(France)
  • Johnson & Johnson (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Bayer AG (Germany)
  • VIVITROL (Ireland)
  • Elsevier (Netherlands)
Select User Access Type

Key Highlights of Report


Jul 2022 156 Pages 88 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Opioid Withdrawal Treatment Market Quantitative research analysis
Global Opioid Withdrawal Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Merck & Co. (United States), Teva Pharmaceutical Industries Ltd (Israel), Pfizer Inc. (United States), Novartis International AG (Switzerland), Sanofi S.A.(France), Johnson & Johnson (United States), F. Hoffmann-La Roche Ltd (Switzerland), Bayer AG (Germany), VIVITROL (Ireland) and Elsevier (Netherlands) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Strict Regulations on Supply of Opioids" is seen as one of major influencing trends for Opioid Withdrawal Treatment Market during projected period 2021-2027.
The Opioid Withdrawal Treatment market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Opioid Withdrawal Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Intelligent Care Support Comprehensive Study by Type (Rehabilitation of Auxiliary, Medical Support, Home Health Care, Other), Application (Home, Pension Agency, Hospital, Other) Players and Region - ...
$ 3800
Health Coaching Comprehensive Study by Coaching Type (Physical Activity, Nutrition & Eating Habits, Weight Management, Diabetes Prevention, Medication Adherence, Other), End User (Fitness Facilities ...
$ 3450
Targeted Protein Degradation Comprehensive Study by Type (Degronimids, IMiDs, PROTACs, SARDs, SERDs, Specific BET & DUB Inhibitors), Application (Healthcare), Therapeutic Area (Inflammatory Disorder...
$ 3650
Biosimilar Testing Service Comprehensive Study by Type (Pharmacokinetic Assay, Tiered Immunogenicity Testing, NAb Assays), Application (Pharmaceutical and Biopharmaceutical Companies, Contract resear...
$ 3800
Ophthalmic Data Management Systems Comprehensive Study by Deployment Mode (Cloud-Based, Web-Based), Disease Type (Glaucoma, Diabetic Retinopathy, Refractive Error, Age-Related Macular Degeneration, A...
$ 3750
Weight Loss and Diet Management Comprehensive Study by Application (Child, Teen Weight Management, Adult Weight Management, Geriatric Weight Management), Diet Type (Paleo Diet, Low Carb, Keto Diet,...
$ 3800